Guggenheim Capital’s Aravive, Inc. Common Stock ARAV Stock Holding History

Guggenheim Capital’s Portfolio ARAV Stock Details ARAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-139,107	Closed	-$1.38M	–	2658
2018 Q1	$1.38M	Sell	139,107 -11,623	-8%	-$131K	﹤0.01%	1890
2017 Q4	$1.99M	Buy	+150,730	New	+$1.94M	﹤0.01%	1670

Other funds holding ARAV

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ascend Capital Orinda, California $1.99B AUM 10.37% 1-Year Est. Return

Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Guggenheim Capital's ARAV Position: Q2 2018 in Review

Guggenheim Capital sold out of Aravive, Inc. Common Stock (ARAV) in Q2 2018, closing a stake of 139,107 shares — an estimated $1.38M sold.

Guggenheim Capital first reported a position in ARAV in Q4 2017 and held it in 2 quarters. The position peaked at $1.99M in Q4 2017. 61 funds tracked by Wall St. Rank hold ARAV as of Q2 2018.

Guggenheim Capital reported no remaining Aravive, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
Guggenheim Capital sold 139,107 Aravive, Inc. Common Stock shares in Q2 2018, an estimated $1.38M.
Guggenheim Capital first reported a position in Aravive, Inc. Common Stock in Q4 2017 and held it in 2 quarters.
Guggenheim Capital's Aravive, Inc. Common Stock position peaked at $1.99M in Q4 2017.
61 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q2 2018.

Based on Guggenheim Capital's 13F filing for Q2 2018, filed 14 Aug 2018.